SCHEMBL24511331

SCHEMBL24511331

NC(=O)CN1CCN(CC(N)=O)CCN(CC(=O)NCC2CCCCC2)CCN(CC(N)=O)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.54
NPC1 O15118 2/20 0.54
LMNA P02545 2/20 0.54
MAPK1 P28482 2/20 0.54
ALOX15 P16050 1/20 0.54
POLB P06746 1/20 0.52
PKM P14618 1/20 0.52
ALDH1A1 P00352 3/20 0.46
SIGMAR1 Q99720 5/20 0.46
CYP2D6 P10635 1/20 0.45
EPHX1 P07099 2/20 0.45
KDM4E B2RXH2 1/20 0.45
CA12 O43570 3/20 0.44
CA1 P00915 3/20 0.44
CA2 P00918 3/20 0.44
CA9 Q16790 3/20 0.44
RAB9A P51151 2/20 0.44
MITF O75030 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24510719 0.94 TSHR (0.50) TSHRNPC1LMNAMAPK1ALOX15
SCHEMBL24511018 0.91 TSHR (0.47) TSHRNPC1LMNAMAPK1ALOX15
SCHEMBL9034674 0.87 ALDH1A1 (0.61) TSHRNPC1LMNAMAPK1ALOX15
SCHEMBL24511010 0.86 TSHR (0.44) TSHRNPC1LMNAMAPK1ALOX15
SCHEMBL18237266 0.86 NPC1 (0.55) TSHRNPC1LMNAMAPK1ALOX15
SCHEMBL13186244 0.83 ALDH1A1 (0.61) TSHRNPC1LMNAMAPK1ALOX15
SCHEMBL15224105 0.78 TDP1 (0.57) TSHRNPC1POLBALDH1A1CYP2D6
SCHEMBL24511015 0.77 LMNA (0.48) TSHRNPC1LMNAMAPK1ALOX15
SCHEMBL23523479 0.76 CYP2D6 (0.49) TSHRPOLBPKMCYP2D6EPHX1
SCHEMBL15224298 0.75 EPHX1 (0.52) TSHRNPC1CYP2D6EPHX1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022123462-A1 RADIOLABELLED PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITORS AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2022-06-16 WO disclosed